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CHAPTER I
THE PROBLEM ALL DEFINITIONS OF TERMS USED
In 1957, Nagao Nishimura made a rather startling
proposition that linked collagen disease with hereditary
metabolic defects. 74

The postulated defect interfered

with the metabolism of phenylalanine and tyrosine re
sulting in the excretion of a hypothetical abnormal
metabolite, 2,5-dihydroxyphenylpyruvic acid.

To support

his hypothesis he treated a series of 26 diffuse collagen
patients by dietary restriction of phenylalanine and
tyrosine with impressive results. 75
cally Japanese.

The diet was typi-

A refined gelatin was used as the protein

source.
The work of Centerwall and Acosta-^3 published in
I960 included a diet with a controlled low intake of
phenylalanine for phenylketonuric infants.

The protein

source was Lofenalac, a low phenylalanine casein hydroly
sate with added fats, carbohydrates and minerals,

It

was therefore suggested that Lofenalac be used as the
major protein source for a low phenylalanine and tyrosine
diet for adult collagen patients.
The object of this study was to observe the effects
of dietary restriction of phenylalanine and tyrosine upon
collagen disease as evidenced by changes in clinical
progress, sedimentation rate and latex fixation tests.
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It was desired to determine the effectiveness and prac
ticability of the use of Lofenalac as the source of
protein for adults on diets restricted in aromatic
amino acids.
The multiplicity of factors involved in the path
ogenesis of collagen disease constitutes a medical jig
saw puzzle.

The search continues for the key pieces

that will enable all the parts to fall into their proper
relation to each other.
The pessimistic prognosis and increasing incidence
of the rarer collagen diseases 30,57,96 and the prevalance
of disability from rheumatic fever and rheumatoid arthritis 78,82 lend urgency to investigations that give
promise of relief.

If Nishimurafs hypothesis should

prove valid some of the puzzling paradoxes of collagen
disease would be elucidated.
The definition of the term "collagen disease"
is elusive. Generally, disorders so designated
have in common the following features: (1) un
known etiology; (2) variable involvement of tissues
of mesenchymal origin; (3) they are usually, al
though not always, characterized by fibrinoid degen
eration and frequently by hypergammaglobulinemia;
(4) poor prognosis; (5) diverse clinical manifes
tations reflecting multiple system involvement;
(6) a favorable albeit often temporary response to
steroid therapy; and (7infrequent clinical and
pathologic similarities.-^0
Included usually in the classification of collagen
disease are acute rheumatic fever, rheumatoid arthritis,
systemic lupus erythematosus, scleroderma, polyarteritis

3
nodosa, thrombotic thrombocytopenic purpura, and dermatomyocitis.

There is some lack of agreement as to which

diseases should be included in the classification.

CHAPTER II
REVIEW OF THE LITERATURE
Hernial Connective Tissue.

Early in the 20th century

Schade called attention to the structure of connective
tissue and especially to the amorphous colloidal nature
of the ground or cement substance in which the cellular and
fibrillary components are imbedded,

He called it the "con-

nective tissue organ" and considered it to have important
physiological functions. 62
The connective tissue system is the extracellular
framework or supporting system of the body.

It is composed

of structural elements or fibers set in a nonstructural
matrix or ground substance. 61 ,63

The fibroblasts respon

sible for the elaboration of fiber and matrix substances
are quite scattered and inactive in adult tissue but are
numerous in growing or healing connective tissue.

Mast

cells that produce heparin and macrophages or wandering
cells are also present.

Lymphoid cells of the connective

tissue are credited with the production of antibodies by
some. 30
The fibers are of two kinds, collagenous and elastic.
Collagen represents approximately thirty per cent of the
total body protein.

It is a fibrous protein occurring in

wavy, birefringent bundles of unbranched acidophilic fibrils
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cemented together in a polysaccharide matrix.

Collagen

forms gelatin if treated with boiling water and contains
large amounts of proline, hydroxyproline, glycine and very
small amounts of aromatic amino acids.

The argyrophilic

reticulin or pre-collagen fibers also occur in wavy parallel
bundles but are arranged more haphazardly.

They form a fine

and delicate supporting network for structures like the
spleen and vascular endothelium.

They are smaller aggre

gates of the same macromolecular fibrils that compose
collagen fibers. 26,41
Elastic fibers are characteristically branched and
smooth and have a yellow color in contrast to the white
collagen.

They are scarce except in certain areas such as

ligaments and arteries.

They contain no hydroxyproline.

Degenerating elastic fibers reveal an affinity for calcium
and mucopolysaccharide.
The ground substance is formed of mucopolysaccharides,
one group of which are chondromucoids. 49

These are highly

polymerized long chain compounds composed of glucuronic
acid, galactosamine, sulfuric acid, and acetic acid loosely
combined with protein.

Mucopolysaccharides are abundant in

the cementing substance where toughness is needed.
also have an ion exchange function.

They

Hyaluronic acid,

another type of polysaccharide, is similar except that it
contains no sulfuric acid and is found where lubrication
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is the prime need as in the eye and joint spaces.

The

capacity of mucopolysaccharides to form either viscous
lubricating fluids or stable tissue matrix depends upon
flexibility in the degree of polymerization. 41
Support, continuity, integrity, and lubrication are
provided by connective tissue.

It also supplies the deli

cate balance between barrier and transport function in the
movement of metabolites, water, electrolytes, and nutrients
between the blood and tissue cells.

(,The aggregate state of

hyaluronic acid and the nature of its bonds with protein
determine intercellular exchange and barrier function." 10
Enzymes, enzyme inhibitors, vitamins, and hormones must be
present in intricate pattern for all these functions to
proceed normally.
Pathological Changes in Connective Tissue.

The term

"fibrinoid degeneration”, frequently used to describe
damaged connective tissue, arises from a similarity to
fibrin of the necrotic collagen in its response to dyes.
However, this response is not consistent and there are
various changes in structure described as hyaline, granular
or fibrillary.

There may also be seen degenerative, inflam

matory and hypertrophic changes at the same time in very
close proximity.
"The regular fiber pattern of normal connective
tissue is replaced by swollen, indistinct bundles or clumps

7
of amorphous material. fr4l

The intercellular ground sub-

stance, scarcely visible in normal tissue, is more pronounced in pathological tissues.

"There are three principle

reactions of connective tissue to injury:

fibrinoid

necrosis, fibrillary augmentation leading to sclerosis, and
cellular invasion and proliferation.”

Cortisone inhibits

fibroplasia; desoxycortisone acetate and growth hormones
accelerate it.

The spreading action or increased permeabil

ity induced by hyaluronidase is inhibited by ACTH and
indirectly by vitamin 0. 10 In the absence of vitamin 0
hydroxyproline is not formed therefore no new collagen is
laid down.

With advancing age the collagenous component

increases and the mucoid content decreases resulting in less
elasticity of the tissues.

The pathological changes in the

connective tissue of collagen diseases do not adequately
account for all of the profound systemic changes observed.
Autoimmunization.

Death from anaphalactic shock

due to sensitization by intracellular proteins released by
massive injury is described as "crush syndrome."

Death

from anaphalactic shock has been reported as occurring in
collagen disease. 88,89

The inclusion bodies of the typical

L.E. cell of systemic lupus erythematosus are demonstrated
to be nucleoprotein.^’^

Without question autoimmuni

zation plays a prominent part in the pathology of collagen
disease.

Is the cell damage with consequent release of

8
D1TA protein 8 a part of the sensitizing process or a result
of some other factor?

Does the depolymerization of nuclear

proteins release tyrosine to accumulate or does defective
tyrosine metabolism with associated conditioned ascorbic
acid deficiency initiate the disorganization as suggested
by Boscott? 23
Antimyosin antibodies have been observed in connec
tion with injured muscle fiber.

Could these be the result

of the same insult that causes the muscle weakness variously
manifested in collagen disease, or do they produce that
weakness?
Tyrosine and vitamin 0 are implicated in the activity
of the adrenals and the formation of epinephrine.

Endocrine

influences upon allergic reactions are only partially underCortisone and vitamin C are both involved in sensitivity and immune reactions 42 and both inhibit depolymeristood.

zation of the glycoproteins of the cementing ground
substance of connective tissues. 1 o Rise of serum glycopro
teins due to depolymerization and/or failure to become
polymerized occurs in scurvy, 79 acute infections, rheumatic
fever, and in cancer, 58

The rise in plasma glycoproteins

which may be due to vitamin C deficiency is measured by
tyrosine content.

The close correlation between alpha2

globulin and mucoprotein tyrosine suggests that this frac
tion of the plasma proteins may contain the serum mucoprotein. 66,102

9
The fibrinoid degeneration of connective tissue
found in collagen disease is characterized by excessive
ground substance with a high content of tyrosine-tryptophane containing protein.
similar composition. 2Q^

Eheumatoid nodules are of

The hematoxylin bodies, hyaline

thrombi, L.E. cell inclusion bodies, and wire loop lesions
common to systemic lupus erythematosus are also high in
tyrosine and tryptophane, 8

Holman 54 says they appear to

be products of an abnormal immune system rather than responsible pathogens,

They are thought to be traceable to

disrupted cell nuclei where such proteins in combination
with nucleic acid form the nucleoproteins.

This same type

of material is indicted in the type of immunization termed
skin graft immunity.

1 ft

Metabolism of Phenylalanine and Tyrosine,

The

animal body is unable to synthesize the benzene ring.60
Phenylalanine and tyrosine are the chief sources of it
in food.

The first step in the metabolism of phenyl

alanine appears to be irreversible conversion to tyrosine.
Por this reason phenylalanine can be used by the body in
place of tyrosine but tyrosine cannot substitute for
phenylalanine.

This reaction takes place in the liver of

man, the enzyme requiring molecular oxygen and diphosphonucleotide (DPH) or triphosphonucleotide (TPN).
is further catabolized by a liver enzyme system.

Tyrosine
The

10
amino group is lost to ketoglutarate by transamination 28
yielding hydroxyphenylpyruvic acid and glutamic acid.
Vitamin C is necessary to the formation of 2,5-dihydroxyphenylacetic (homogentisic) acid.

How the arrangement of

the two hydroxyls takes place is not known.
The opening of the ring by the enzyme homogentisicase, a liver oxidase, results in the formation of fumarylacetoacetic acid.

This acid splits by hydrolysis into

fumaric and acetoacetic acids.

Pumaric acid enters the

citric acid cycle while acetoacetic acid follows the
pQ

regular path of fat metabolism.

Both phenylalanine

and tyrosine are completely utilized by the normal body.
These pathways are graphically presented in Figure 1. 4,28,
60,70,74,75,95,99
Phenylalanine is also partly oxidatively deaminized
to phenylpyruvic acid.

Another hypothetical intermediate

is 2,5-hydroxyphenylpyruvic acid which yields homogentisic
acid by decarboxylation and oxidation.

Some urinary

hippuric acid is thought to be of endogenous origin from
phenylalanine.
The production of certain pigments by another
metabolic pathway in which tyrosine takes part is of
interest.

Tyrosine is oxidized to dihydroxyphenylalanine,

(or ”l)opa”) then to a red indole compound (5,6-dihydroxyindole) by an oxidizing enzyme, tyrosinase.
converted to melanin.

This is

Melanins are brown or black substances
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of unknown composition found in skin, hair, the choroid
coat of the eye, and melanotic sarcomas.

That their

formation is aided by light is demonstrated by the produc
tion of freckles and tanning upon exposure of the skin to
sunlight. See Figure 2. 4,19,60,70
Suggested pathways for the synthesis of epinephrine
and thyroxine from tyrosine are represented in Figures 3
and 4.

Norepinephrine is the primary adrenergic agent.

Triiodothyronine is five times as active as thyroxine and
is thought to be formed by deiodination of thyroxin.

These

pathways are summarized in Figure 5.
Tyrosine is a reducing agent of considerable impor
tance and derives this property from its hydroxyl group.
Requirements for Phenylalanine and Tyrosine. Rose
and collaborators tentatively proposed a minimum require
ment for phenylalanine of 1.1 gm. and a safe intake of
2.2 gm. per day for the adult human male. 52

This proposal

was the result of six quantitative experiments in which a
range of 0.8 to 1.1 gm. were required daily to maintain
nitrogen equilibrium. According to Albanese, 4 male infants
require 169 mg. phenylalanine per kilogram per day, a higher
requirement than that of the adult.

Leverton reports a

minimum daily requirement of 220 mg. phenylalanine in the
presence of 900 mg. tyrosine for college women. 106
The requirement may be partially but not completely
replaced by tyrosine.

This sparing action of tyrosine may
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SUMMARY OF METABOLIC SCHEMES
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cover 70 to 75 per cent of the phenylalanine requirement.
Human cells in tissue culture are not able to convert
phenylalanine to tyrosine efficiently enough to permit
growth. 107
D-phenylalanine is utilized but cannot completely
replace the L-isomer.
Symptoms of phenylalanine deficiency are negative
nitrogen balance, cessation of growth, inanition, reduced
hemoglobin and plasma protein — the nonspecific evidences
of protein malnutrition.
Since practically all food proteins contain about
5 per cent of phenylalanine by weight there is no possi
bility of a dietary deficiency if the protein intake is
adequate. ^>70
Protein Metabolism.

Nitrogen balance in the adult

organism can be established at various levels of protein
intake.

How much longer the scientific controversy will

wage over which level is optimum will depend upon the
development of adequate critera for correct evaluation.
Increased strength and vigor on the basis of subjective
evaluation has been claimed both by advocates of low

pro

tein regimes and by proponents of high protein intakes.59
The high levels of protein intake that produce'maximum
growth in the young animal are not necessarily optimum
for health and longevity. 75,76,85,104,105

Neither can it

be said that balance at the lowest possible level could be

17
optimum for vigor and disease resistance. 107
Scrimshaw, Guzman, and de la Vega 91 were puzzled by
the observation that central American children on protein
intakes marginal in amount revealed higher serum albumin
levels than children in the United States with much more
liberal intakes.

Such observations are reassuring to

research in which low protein diets are used without alter
native.
Hereditary Metabolic Disease.

The study of inherited

abnormalities of metabolism has contributed much to the knowledge of the metabolism of phenylalanine and tyrosine. 4,20,70,65
These diseases (albinism, alcaptonuria, phenylketonuria) are
the result of biochemical errors or metabolic blocks in the
intermediary pathways of phenylalanine and tyrosine metabolism
graphically illustrated in Figure 1.

The symptoms may be

varied and far removed from the site of the underlying abnor
mality.

Indirect consequences of the absence of normal

products or of the accumulation of abnormal metabolites are
the subjects of much investiga.tion. 17,19,43,65,95
Uishimura’s^ hypothetical block which postulates
that 2,5-dihydroxyphenylpyruvic acid is an abnormal metabo
lite classifies collagen diseases as heriditary metabolic
disorders.

It has been reported that a group in France have

supported his findings. 95 Whether the obvious abnormal metabo
lism of aromatic amino acids in collagen disease is a primary
defect or a secondary effect awaits elucidation.
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Interrelationships.

The place of pyridoxine in the

metabolism of phenylalanine and tyrosine has been pointed
out.

Thiamine, as cocarboxylase, may also be essential to

the decarboxylation of all keto acids, 97

In vitro studies

with guinea pig slices revealed a failure of scorbutic
tissue to oxidize the side chain of tyrosine.

Polacin

prevented the hydroxyphenyluria from tyrosine feeding of
scorbutic guinea pigs but did not prevent scurvy.
work was not verified in monkeys or infants.

This

An enzyme

from rabbit liver has been shown to convert para-hydroxyphenylpyruvic acid to 2,5-dihydroxyphenylpyruvic acid in
the presence of vitamins C and B 12- Homogentisicase, the
liver oxidase which cleaves the ring is greatly reduced in
livers from scorbutic animals.

The activity can be restored

either by vitamin 0 or by ferrous ions which are required
for enzymatic oxidation of homogentisic acid.

It is there

fore concluded that vitamin C has a nonspecific effect as a
reducing agent maintaining iron in the ferrous state. 23,27
The sulfur-containing amino acids, such as methionine,
contribute methyl groups for the transformation of tyrosine
to epinephrine.

Tyrosine is found in normal human urine as

the ortho-sulfate derivative and apparently occurs in this
form in fibrinogen.

Ascorbic acid oxidation-reduction

reactions involve SH groups such as are supplied by gluta
thione. 71
The abnormal pigmentation characteristic of Addison1s
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disease is evidence of some relation of the adrenal gland
to the metabolic pathway from tyrosine to melanin.

Abnormal

pigmentation occurs also in scurvy, scleroderma, lupus erythe
matosus, and certain hereditary metabolic diseases.
Tyrosine transaminase and dihydroxyphenylalanine
decarboxylase require pyridoxine as a coenzyme.

The vita-

min Bg group is indispensible to most phases of protein
metabolism. 1,5,16,56,103,109
Since tyrosine is oxidized by transamination with
alpha-ketoglutaric acid which is a product of the citric
acid cycle, anything that interferes with normal energy
metabolism can hamper tyrosine metabolism.

Pyridoxine,

niacin, thiamine, riboflavin, and pantothenic acid are all
essential in the citric acid cycle.
There is a close relationship between the metabolism
of phenylalanine and tyrosine and that of tryptophane. 17,71
98,109
Collagen Disease.

Dubois, 33 working at the Los

Angeles County Hospital, has accumulated a sizeable series
of collagen cases.

He calls it "the overlooked diagnosis"

and directs attention to the great variety of symptoms
that may be presented. These are truly multiple system
diseases. He reports 34 an incidence of lupus erythema
tosus greater than that of leukemia, Hodgkin’s disease
and pernicious anemia and one half that of rheumatic
fever. 36 Much collagen disease is masquerading under
some other diagnosis.

It seems to be steadily on the
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increase.

Kampmeir-^ suggests as possible causes for the

increased incidence, the almost universal exposure to drugs
during the past twenty-five years and "for the first time an
inordinate exposure of the lightly pigmented Caucasian shin
to sunlight in the pursuit of ’sun worship’."

Drugs may act

as sensitizers and sunlight may stimulate autoimmunization.
It is well known that exposure to sunlight may precipitate
serious consequences in collagen disease.57,88
There is such a close interrelationship between the
various collagen diseases that differential diagnosis is
difficult if not impossible.

Often one will in time progress

into or be superimposed upon another. 13,24,44,49,57,66,73,80,
84,93
Thus what appears to be a typical rheumatoid arthritis
turns out to be a case of lupus or scleroderma.

Lupus is

often mistaken for rheumatic fever or polyarteritis and at
times has been confused with the other members of the group.
Polyarteritis has been mistaken for or associated with rheu
matic fever.

Some contend that scleroderma and dermatomyo-

sitis are really the same disease.

"This strong clinical

overlapping as well as the presence of a similar pathology
may possibly suggest that diseases of collagen are but various
stages or fractions of the spectrum of one and the same disease."

Dubois 33 Klemperer 63 and Baehr 26,57 contend that each

is a distinct disease entity and never overlap or progress
from one to the other.
Some type of pulmonary involvement is almost certain
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to occur at some time during the course of a collagen disease. 11
It is sometimes difficult to tell if this is an integral part
of the disease or a complication.

The pulmonary symptoms

are of a wide variety and non-specific in character.
The collagen diseases as a group have been considered
recurrent and incurable with a poor prognosis.
has been supportive and symptomatic.

Treatment

Steroid therapy has

been more successful than anything yet tried. 35

It often

produces spectacular results and usually affords at least a
degree of relief. 25,51,59,67,72,86,92
The side effects of corticosteroid therapy such as
increased appetite, hirsutism, moon facies, and other symp
toms of Cushing's syndrome must be carefully watched.

Stimu

lation of the gastrointestinal tract producing peptic ulcers
and multiple hemorrhages of the intestinal mucosa is a serious
effect especially since such conditions may be produced by
the disease itself.

Severe muscle weakness and atrophy,

striae, and ecchymoses are other symptoms that might indicate
an accentuation of existing symptoms particularly of dermatomyocitis and purpura.

Disturbances of water and mineral

balance are also factors to be seriously considered in a
group of diseases in which heart and kidney involvement are
to be expected.
Diet modification during steroid therapy is common.
There may be routine sodium restriction, potassium supple
mentation, and prophylactic ulcer diet.

However some steroids
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do not require sodium restriction.

Occasionally calorie

restriction is required to control weight in long term steroid
therapy.
High protein, high vitamin and mineral diets are
usually recommended.

High calorie diets have been considered

necessary to combat the emaciation and wasting.

If there is

dysphagia it may be necessary to try to meet the nutritional
needs of the patient with nourishing liquids.

Diets must

be modified to meet the various crises through which the
patient passes depending upon the specific organs affected.
There is a current report of excellent results obtained in
the treatment of rheumatic fever with B factors^ a.nd heavy
doses of vitamin C.

This has not been substantiated. 108

Rheumatoid Arthritis

Like rheumatic fiver rheuma

toid arthritis is characterized by disseminated arteritis,
pancarditis, polyarthritis, and subcutaneous nodules containing
gamma globulin and deposits rich in tyrosine and tryptophane.
However unlike rheumatic fever it is accompanied by crippling
arthritis involving both joints and muscles,

It is three

times as frequent in females as in males, is prevalent in
the temperate zone and rare in the tropics, and is essentially
a disease of young people, the average age at onset being
Op

thirty-five years.

The etiology in common with other col

lagen diseases is unknown,

Precipitating factors may be

listed as shock,^ prolonged fatigue, trauma, infections,
exposure, constitutional inferiority and heredity.

Treatment
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includes physical therapy, 78

salicylates, removal of foci of

infection, gold therapy and steroids.

There is some evidence

that steroid therapy may lead to the development of polyar
teritis nodosa in patients with rheumatoid arthritis.
The various diets suggested in the past have "been
largely rejected.^2

Low calorie diets may markedly interfere

with optimum nutrition for many of these patients are mal
nourished and anorexic.

Since the decreased carbohydrate

tolerance observed in this disease is probably caused by
the chronic inflammatory state rather than defective sugar
metabolism the low carbohydrate diet has also been rejected.
The benefits attributed to these diets were probably due to
the increased intake of minerals, vitamins and protein by
the elimination of f,empty calorie" foods.
vitamin 1 are now considered dangerous.

Massive doses of
Excess dosage of

other vitamins and minerals have not proved beneficial.
The victim of rheumatoid arthritis has a systemic disease
and is a sick individual.

He has a negative nitrogen and

calcium balance with muscle atrophy and decalcification of
bone.

The progressive, inflammatory tissue disorder goes

on for years.
Bayles26

Good nutrition is of fundamental importance.

suggests about 150 gsi. carbohydrate, 80 - 100 gm.

protein, and 80 - 100 gm. fat depending on the patient*s
relation to normal weight.

Fresh fruits and vegetables should

be emphasized.
Scleroderma.

Scleroderma is characterized by diffuse
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induration and immobility of the skin with pigmentation,
sclerodactylia and arthritis.
involved.

The face and hands are usually

Beginning symptoms are suggestive of Reynaud‘s

disease.
The cutaneous changes pass through several stages,
the first of which is a brawny edema. Then the skin
becomes smooth, waxy, hard and tight so that it cannot
be lifted from the deeper structures. As the disease
advances to the atrophic stage, the skin becomes
thinner, smoother and completely adherent to the
shrunken muscles. The movement of joints is progres
sively restricted until the patient resembles a living
mummy.2^
A mask like face is characteristic.

Frequently there

is brownish pigmentation of the skin, also depigmentation
in severely affected areas.

Calcium deposits may form in

the diseased portion.

Calcium sludge may extrude from the

ends of the fingers.

loss of hair, coldness of the digits

and painful ulcers may occur.

The esophagus frequently

becomes enlarged and stiffened with resulting dysphagia.
Peculiar fibrosis of the heart, lungs and kidneys are serious
complications.

Death may follow in a few months in acute

cases but usually the process requires years for full development. 26,96 In 1868 Addison described the affected part
as becoming "hide-bound" to such an extent that "the whole
of a limb, but especially the fingers may be permanently
contracted, bent, and rendered almost as hard and immovable
as a piece of wood; thereby impeding progression, distorting
the gait, and making the patient a poor miserable cripple
for the remainder of his life. u96
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Treatment is entirely symptomatic and supportive
consisting of warm baths, massage, heat, softening ointments,
high calorie, high vitamin diet, and removal of foci of in
fection*

Short steroid courses are used but may give rise

to malignant hypertension or arteritis nodosa.
has been used. 96

Sympathectomy

CHAPTER III
RESCRIPTIOH OP METHODS USED
Selection of Patients.

Patients for this study were

selected on the bases of (1) severity of clinical symptoms,
(2) psychological ability to cooperate, (3) positive latex
fixation, and (4) elevated sedimentation rate.
Test Diet.

The test diet was set up to contain no

more than 1500 mg. daily of phenylalanine and tyrosine
combined.

This was achieved by the use of Lofenalac (see

Appendix for composition) as the major source of protein.
One cup (144 gm.) of Lofenalac furnished 24 gm. of protein
and 120 mg. each of phenylalanine and tyrosine.

Low protein

foods# were selected to bring the total daily protein to
36 gm. and the phenylalanine and tyrosine to not more than
1500 mg.

In most cases, inbetween meal nourishments of

vegetable consomme were served to increase the supply of
minerals and vitamins with little increase in protein.

A

vitamin supplement (see Appendix) was given during the entire
test period.
Patients were asked to keep some pure sugar candy
at hand to use only if a meal seemed particularly unsatisfying.

Small amounts of Seven-up were also permitted.

Tobacco, tea, coffee, and alcohol were not to be used during
the period of study.
# See Appendix.

Any portion of meals not eaten was
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to be returned to the kitchen to be weighed.
Since the patients were to remain on the test diet
following the 10-day hospitalization period they were given
thorough diet instructions during the time they were hospital
ized.

Sample exchange lists, hospital menus and home instruc

tions are included in the appendix.
Medications.
ued.

All previous medications were discontin-

Ten grains of aspirin were to be given every four hours

for pain, if needed.

Nembutal, one and one-half grains, was

to be given as necessary for sleep.
Time Involved.

Dietary restriction of phenylalanine

and tyrosine was prescribed for seven patients with collagen
disease for a period of six weeks.
quired for the first ten days.

Hospitalization was re

The diet was continued under

home supervision for the remainder of the experimental period.
Laboratory Tests.

Samples of blood and 24-hour urine

specimens from each patient were submitted for laboratory
analysis at the time of admission to the hospital.

The

analyses were repeated at weekly intervals for a period of
six weeks.
Blood determinations included glucose, hemoglobin,
hematocrit, sedimentation rate, total protein, albumin,
globulin, albumin-globulin ratio, thymol turbidity, and
rheumatoid arthritis (R.A.) latex globulin test, 38
hospital routine tests also are reported.
were frozen for tyrosine determinations.

Other

Serum samples
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Urine determinations included, in addition to hospital
routine, creatinine and urea nitrogen.
The reagents for the rheumatoid arthritis latex globulin
test were obtained from the Hyaland laboratories and the thy
mol turbidity liver function measurements from Shank and
Hoagland.

The liver function tests were uniformly normal

and were discontinued after a few weeks.

The total serum

protein for the albumin-globulin ratio was by the KingsleyBiuret method.

The urine creatinine was determined by the

standard picrate procedure.

Urea nitrogen was determined by

a microphenate-hypochlorite method developed by the Chaney
laboratories and distributed by Hyaland.

The total 24-hour

nitrogen values for the nitrogen-creatinine ratio 81 was
approximated by increasing the sum of the urea and creatinine
nitrogen by five per cent.

These determinations are as yet

incomplete.
The frozen serum specimens for the beginning and the
end of the experimental period for cases 1 and 2 have been
sent to the Chaney laboratories for tyrosine determination.
These are not yet completed.

CHAPTER. IV
STATEMENT OE RESULTS OBTAINED
The accompanying graphs, Figures 6 to 12, plot the
changes in hematocrit, sedimentation rate, albumin globulin
ratio and latex fixation tests in all patients.
It is of interest to note that these six patients
(excluding case number 5), on a marginal intake of not more
than 36 grams of protein daily and about 1500 calories (more
for one of the men) for six weeks showed an average decline
in hematocrit of only 1.1.

One showed a slight rise, two

remained quite constant, and one shows unreasonable variation.
Case number 4, who dropped out because of vomiting, was not
included in the average.

Her reports were included because

there was a drop in both A.G. ratio and R.A. latex fixation
during her stay in the hospital.

When she went home, the

R.A. fixation rose again which was of interest because it
was obvious that she was not cooperating.

The scale for

the R.A. latex fixation was set up arbitrarily to express
the degree of agglutination.
albumin.

There was no drop in serum

Body weights were held constant and there was no

evidence of deterioration of nutritional state.
The following case reports summarize the individual
results:
Case number K A 48-year-old white man was admitted
as a research patient March 10, 1961. He had been unable
to work for three months due to an arthritic knee ;}oint
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and could not walk without crutches or bend the inflamed
knee. The latex fixation test was definitely positive
but not strongly so. Synovial fluid removed from the
knee showed poor mucin precipitate with shreds and cloudy
solution.
On the day following admission, his diet was reduced
from 2000 calories to 1500 because "it was too much"
for him. He preferred his Lofenalac unflavored. He
was easy to please and very cooperative with those res
ponsible for working out the details of a new and rather
difficult dietary regime. On the third day there was
some improvement, on the fifth day he could bend his
knee better than 100° without pain. When he left the
hospital after ten days the knee has stiffened and
could flex only to about 40° but there was no pain.
He walked out without crutches and went to work the
next day. He lost three days work after spraining his
ankle April 5. This injury was followed by much pain
and swelling which was discouraging to him. He complain
ed of persistent halitosis which he attributed to the
Lofenalac. He has continued to improve with ups and
downs. He was anxious for a beefsteak the Sunday
following the end of the experimental period but re
ports that he still stays on his diet "most of the
time" and feels well rewarded for his effort. The fact
that he is a strict Catholic and was admitted during
Lent may have influenced his beginning laboratory find
ings.
Case number 2. A 42-year-old white woman was admitted
March 15’ 19&1. Her illness began four years before with
pain and swelling of the left shoulder so severe as to
require hospitalization and injections. Six months later
both shoulders, knees, and feet were involved. She spent
three weeks in the Pinehurst Clinic, wheeler, Oregon.
Except for waning of acute flare-ups she felt she had
made no improvement but had been gradually getting worse.
She has been taking cortisone for a year and has required
15 to 20 aspirins daily. Her hands and wrists were swollen
and painful. She could not comb her own hair and brushed
her teeth with great difficulty in a contorted position.
She could get down steps by going backwards with support.
She would be more helpless if she were not so spirited
and courageous. During her first few days in the hospital
she had headaches, probably due to a lack of coffee. She
improved slowly but steadily without cortisone and with
aspirin only occasionally. She followed her program
faithfully after leaving the hospital. She went home to
Idaho happy to be able to comb her hair, brush her teeth
and hold a gun for target practice with her husband. The
physiotherapist who had treated her previously was impress
ed with the improvement in her joints. She wishes to
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continue her diet.
Case number
A 59-year-old white male with degen
erative arthritic joint changes of ten years duration
was admitted March 20, 1961. A number of conspicuous
rheumatoid nodules made this patient of interest for
this study. One nodule was removed for a pathology
report. He was over six feet tall and began to lose
weight on the diet. His calories were increased to
2500 and again to 3000 when he went home to work. On
this intake he neither gained nor lost weight. This
man had a well controlled colostomy which became some
what of a problem on this diet. His improvement was
definite but not at all spectacular. There was no
change in the nodules. However he came into the doctors
office on May 11 feeling much improved and very happy
about it. His knees and wrists were much less painful.
Case number 4. A 40-year-old white female was ad
mitted March 17, 1961 with stiff, swollen, and painful
right shoulder, elbow, knee, ankle and both feet. Present
illness began 14 months before. On the third and fourth
days she was considerably improved but was not encouraged
to try to continue because she did not appear to be suf
ficiently stable emotionally to be depended upon. She
decided to stay but was unable to abstain from tobacco
and alcohol. She had vomiting spells on March 22 and 27
and after she went home. Her last report was March 26.
This case is reported only because of the possible sig
nificance in her laboratory reports.
There is a possibility that the vomiting could have
been caused by rapid absorption of free amino acids as
suggested by Wohl and Coodhart.10^ It would have been
advisable to try smaller, more frequent feedings of
the protein digest.
Case number ^>. A 45-year-old Mexican woman with
multiple, painful joint involvement was admitted March
21, 1961. Ho noticeable improvement was observed during
the experimental period.
Case number 6. A 61-year-old Mexican woman with
multiple joint involvement and especially pain in the
neck, shoulders and hands was admitted April 6, 1961.
She complained constantly of pain in spite of medication
and improved very little. Pood was reported smuggled in
to her.
Case number £. A 65-year-old Mexican woman with
scleroderma was admitted March 24, 1961. Present illness is of two years known duration. She is almost
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totally deaf, but very cooperative. The greatest prob
lem was dysphagia. After a few days her intake became
totally inadequate so her days allotment was prepared
in the form of eight liquid feedings given at intervals
of one and one half hours. This was tolerated quite
well. After five or six days she received solid food
again at her request. The stiffness and pain in her
fingers and forearms have improved. There is increased
mobility of fingers and jaw. She is particularly pleased
to be able to "open her mouth” and is very grateful for
the improvement in dysphagia and esophagitis which she
terms "heart burn". She is continuing with supervision
on the diet but often does not eat as much as is pre
scribed.
Case

Arthritis cases 1 and 2 were greatly benefited.

3 was only moderately benefited unless the delayed improvement is attributed to the diet.

Case 4 was unsatisfactory.

Cases 5 and 6 were benefited very little if any.

The sclero

derma case seems to present remarkable improvement considering
the absence of previous remissions.
Neither of the two cases of rheumatoid arthritis
who responded well had strongly positive S.A. tests.

The

two who did not respond at all had very strongly positive
R.A. tests which remained so throughout the experimental
period.

The sedimentation rate paralleled clinical progress

to some extent at least.

CHAPTER V
DISCUSSION
If, when this series of patients is enlarged, clinical
improvement is significant; the same regime, except for the
substitution of soylac or a similar product, should be under
taken in order to determine if the benefit is derived from
curtailment of aromatic amino acids or from lowered protein
intake of some other unavoidable concomitant modifications
of the diet.

Improvement, if due to restriction of phenyl

alanine and tyrosine, could be considered evidence in support
of Nishimura's hypothesis; however, there are other possi
bilities to be considered.

It is conceivable that the

organism, overloaded with the abnormal catabolism of aro
matic amino acids evidenced in certain collagen diseases,
would be benefited by their restriction.

There is also the

possibility that the formation of immune bodies could be
curtailed by such restriction or that the relation of
tyrosine to hormone production could affect endocrine balance.
If aromatic restriction benefits by way of inhibiting
sensitization, the effect of such restriction upon skin
graft immunity might be worth investigation.

Even though

skin graft immunity is species specific and the sensitizing
material of certain collagen diseases is not; the antigen
in both instances is nucleoprotein or desoxyribonucleic
acid.
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The relation of light sensitive dermatoses common in
collagen disease to tyrosine as a ffsun trap”^ or to melanin
as an ultraviolet screen raises further questions as to
possible means of interruption of disease processes.
There is the possibility that a drastic change in the
diet may force a readjustment of a disordered metabolism.
If the new regime offers the essential nutrients there could
possibly be therapeutic benefit in the demand for physiolo
gical adjustment to an entirely new order of things,

There

is also the alternate possibility of traums to the organism
from sudden change.
Benefit could be attributed to the abandonment of
unhygienic habits and unwholesome foods, or to increased
consumption of foods high in vitamins and minerals.
In order to accomplish the reduction of aromatic amino
acids in the diet, the protein allowance was lowered to a
marginal level.

Without question there are times when a

negative nitrogen balance renders high protein intake a
life saving emergency measure.

Perhaps there is a need to

explore the idea that pathology produced by or associated
with excessive protein catabolism might be reversed by
lightening the load.

The curtailment of grains and grain

products and natural protein foods poses the problem of
nutritional adequacy and raises the question as to which
of the many modifications of the diet should the results,
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if significant, be attributed.

If the effort to make the

diets as nutritionally abundant as possible in face of such
restrictions resulted in improvement of some dietaries, the
failure to do so would have resulted in worsening of others.
Such a failure could also render ineffectual measures
that might have proved beneficial if all other links in the
metabolic chain were intact.
The Lofenalac was accepted better than anticipated.
Most of the patients found it easier to take if flavored
with molasses.

The pudding recipes developed by Acosta-^

were a very useful means of incorporating part of the
necessary Lofenalac.
this purpose.

Danish dessert was also useful for

Since the thickening agent in Danish dessert

is sta.rch the protein content approximates that of the
pudding recipes.

For patients who did not care for pudding

the two tablespoons of Lofenalac were blended with four
ounces of pineapple juice.
The exchange lists devised by Acosta^ were intended
for the use of infants and small children.
were not very useful for most adults.

The biscuits

One tall man laugh

ingly complained that he lost his biscuits under his honey.
More patient satisfaction was derived from the use of the
bread exchange for cereal in the morning, and potato or
corn at the other meals.
appreciated.

Soda crackers for soup were

Two Mexican patients were touchingly grateful

when it was decided to allow a small portion of corn tortilla
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for the bread exchange.

On Easter the recipes for cookies

and ice cream were used, but in general it was felt that if
the exchanges were filled largely by fruits and vegetables
the diets would be more nearly adequate.
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FIGURE. NO. 7
CftSE. NO. 2
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CHAPTER VI
CONCLUSION
A progress report of a pilot study In which six
rheumatoid arthritis patients and one scleroderma case were
treated with a diet low in phenylalanine and tyrosine is
presented.
The diets supplied approximately 1500 calories and
36 grams of protein.

Lofenalac, a casein hydrolysate,

was the principle source of protein.

The diets were quite

well received, and there were no evidences of inadequate
nutrition.

The scleroderma patient and three of the

arthritic patients improved.
and two did not improve.

One case was unsatisfactory

The sedimentation rates roughly

paralleled clinical progress.

The reports of other labora

tory analyses that have been completed so far do not appear
to be significant.
It is recommended:
1.

That the effect of dietary restriction

of aromatic amino acids be observed upon a larger series
of patients with collagen disease.
2.

That control periods be included in the

experimental plan in which Soyalac or a similar product
shall be substituted for Lofenalac in the diet.
The implications of the confirmation of Nishimura‘s
hypothesis have been discussed.
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6
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cup dry
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3
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5
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3
3
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Fat
Mid morning - vegetable consomme
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Prune juice
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Strawberries
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30 mg. PA
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Rice flakes
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Rice Krispies
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Rice
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EAT EXCHANGE

5 mg. PA

Butter

1 pat

10 gm.

Cream, heavy

1 tsp.

5 gm.

Margarine

1 T

Mayonnaise
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6 gm.

Olives

1 large

6.5 gm.

14 gm.
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Guava Butter
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ABSTRACT
In 1957, Nishimura7^ made a startling proposition that linked
collagen disease with hereditary metabolic defects.
was stated to be in the metabolism of tyrosine.

This defect

Based on this report,

a pilot study was conducted in which six rheumatoid arthritis patients
and one scleroderma case were treated with a low phenylalanine and
tyrosine diet.
The diets supplied approximately 1500 calories and 36 grams of
protein.

No more than 1500 mg. combined phenylalanine and tyrosine
Lofenalac was used as the principle source

were given in any one day.
of protein.

During the six week' test period laboratory studies were carried
out at weekly intervals for determining the following: blood glucose,
hemoglobin, total protein, albumin, globulin, A.G. ratio, thymolturbidity, rheumatoid arthritis latex globulin test, hematocrit, and
sedimentation rate.

Clinical progress was also noted in each individ-

ual.
The diets were quite well received and there were no evidences
of inadequate nutrition.

The scleroderma patient and three

arthritic patients improved.

One case showed unsatisfactory improve-

ment, while two showed no improvement.
paralleled clinical progress.

of the

The sedimentation rates roughly

The reports of completed laboratory

analyses did not appear significant.
It was concluded that bafeeii *011'-results“obtaineci,'. investigation
should be continued before significant‘■fftatemenis could be made.
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